Abstract:Understanding cytochrome P450 (CYP) enzymes in the canine intestine is vital for predicting drug metabolism and developing safer oral medications. This study evaluates canine colonoids as a model to assess the expression and induction of essential intestinal CYP enzymes. Canine colonoids were cultured in expansion medium (EM) with Wnt-3A and in differentiation medium (DM) without Wnt-3A. We assessed the mRNA expression of CYP2B11 , CYP2C21 , CYP3A12 , and CYP3A98 using qPCR and examined the effects of rifampicin and phenobarbital as inducers. Our findings show that DM significantly increased the mRNA expression of CYP3A98 and CYP2B11 , but not CYP3A12 , compared to EM. CYP2C21 , not typically expressed in the intestine, remained unexpressed in colonoids. Rifampicin induced CYP3A98, aligning with pregnane x receptor (PXR) regulation, while phenobarbital did not, suggesting no constitutive androstane receptor (CAR) involvement. CYP2B11 did not respond to either inducer, suggesting alternative regulatory pathways in canine colonoids. This study is a pioneering effort to establish conditions for studying P450 expression in canine colonoids, confirming significant CYP3A98 expression in the canine intestine. It demonstrated colonoids can induce CYP activity post drug treatments. Further research is needed to enhance species-specific drug metabolism understanding and validate this model for broader applications.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the expression and induction of cytochrome P450 (CYP) enzymes in the canine intestinal organoid model. Specifically, the research aims to: 1. **Establish a canine intestinal organoid model**: By using expansion medium (EM) and differentiation medium (DM), evaluate the growth and differentiation of canine intestinal organoids under different culture conditions. 2. **Evaluate the expression of key CYP enzymes**: Focus on studying the expression levels of four CYP enzymes, CYP2B11, CYP2C21, CYP3A12 and CYP3A98, in canine intestinal organoids. These enzymes play important roles in drug metabolism, especially CYP3A98 which is considered as the main drug - metabolizing enzyme in the canine intestine. 3. **Detect drug - induced effects**: Use rifampicin and phenobarbital as inducers to evaluate their effects on the expression of CYP2B11 and CYP3A98. Rifampicin is generally considered as an inducer of the CYP3A subfamily, while phenobarbital is considered as an inducer of CYP2B11. ### Research background Cytochrome P450 (CYP) enzymes play a key role in drug metabolism and detoxification processes. These enzymes are highly expressed in the liver, but their role in the intestine cannot be ignored, especially for the metabolism of oral drugs. The CYP3A subfamily is particularly important because they are highly expressed in both the liver and the intestine and can metabolize a large number of drugs. ### Research methods 1. **Generate and maintain canine intestinal organoids**: - Isolate stem cells from intestinal biopsy tissues of healthy dogs and culture them in Matrigel. - Use expansion medium (EM) containing Wnt - 3A for initial culture, and then continue the culture in differentiation medium (DM) without Wnt - 3A. 2. **Gene expression analysis**: - Use quantitative real - time polymerase chain reaction (qPCR) to evaluate the mRNA expression levels of CYP2B11, CYP2C21, CYP3A12 and CYP3A98. - Compare the gene expression differences of organoids cultured in EM and DM. 3. **Drug - induction experiments**: - Add rifampicin and phenobarbital to the differentiation medium to evaluate their induction effects on the expression of CYP2B11 and CYP3A98. - Use high - throughput liquid chromatography - tandem mass spectrometry (HPLC - MS/MS) to detect the concentration of 1' - hydroxymidazolam to evaluate the activity of CYP3A enzymes. ### Main findings 1. **Differentiation medium promotes CYP enzyme expression**: - In the organoids cultured in DM, the expressions of CYP2B11 and CYP3A98 increased significantly, by 12.4 - fold and 22.8 - fold respectively. - The expressions of CYP2C21 and CYP3A12 did not change significantly. 2. **Drug - induced effects**: - Rifampicin significantly induced the expression of CYP3A98, but had no effect on CYP2B11. - Phenobarbital had no significant induction effects on the expressions of CYP2B11 and CYP3A98. 3. **Physiological relevance of the organoid model**: - This model can accurately reflect the expression and induction of CYP enzymes in the canine intestine, providing a reliable in vitro model for predicting drug metabolism. ### Conclusion This study successfully established a canine intestinal organoid model for evaluating the expression and induction of CYP enzymes. The research results show that the differentiation medium can significantly increase the expressions of CYP2B11 and CYP3A98, and rifampicin can effectively induce the expression of CYP3A98. This model provides a new tool for studying canine drug metabolism and is helpful for developing safer oral drugs.

Assessment of cytochrome P450 induction in canine intestinal organoid models

Assessment of P-glycoprotein function using canine intestinal organoid-derived epithelial interfaces

Evaluation of Tissue Stem Cell-Derived Human Intestinal Organoids, a Physiologically Relevant Model to Evaluate Cytochrome P450 Induction in Gut

A variety of cytochrome P450 enzymes and flavin-containing monooxygenases in dogs and pigs commonly used as preclinical animal models

Crypt Organoids Culture as an In Vitro Model in Studying Regulation of Xenobiotic Metabolism and drug‐induced Cytotoxicity

Traces of Canine Inflammatory Bowel Disease Reflected by Intestinal Organoids

Differential Transcriptomic Profiles Following Stimulation with Lipopolysaccharide in Intestinal Organoids from Dogs with Inflammatory Bowel Disease and Intestinal Mast Cell Tumor

Recapitulation of the accessible interface of biopsy-derived canine intestinal organoids to study epithelial-luminal interactions

Proinflammatory cytokines suppress stemness-related properties and expression of tight junction in canine intestinal organoids

Absolute Quantitation of Drug-Metabolizing Cytochrome P450 Enzymes and Accessory Proteins in Dog Liver Microsomes Using Label-Free Standard-Free Analysis Reveals Interbreed Variability

Canine Mucosal Artificial Colon: development of a new colonic in vitro model adapted to dog sizes

Comparison of inducibility of CYP1A and CYP3A mRNAs by prototypical inducers in primary cultures of human, cynomolgus monkey, and rat hepatocytes

Organoid-derived Duodenum Intestine-Chip for preclinical drug assessment in a human relevant system

Use of RNA-seq to determine variation in canine cytochrome P450 mRNA expression between blood, liver, lung, kidney and duodenum in healthy beagles

Novel Cytochrome P450 2C94 Functionally Metabolizes Diclofenac and Omeprazole in Dogs

Investigating the Utility of Humanized Pregnane X Receptor-Constitutive Androstane Receptor-CYP3A4/7 Mouse Model to Assess CYP3A-Mediated Induction

A Novel Mouse Model for Colitis-Associated Colon Carcinogenesis Induced by 1,2-Dimethylhydrazine and Dextran Sulfate Sodium

A Multi-Tissue Comparison and Molecular Characterization of Canine Organoids

3D MORPHOGENESIS AND BACTERIAL CO-CULTURE IN A CANINE GUT-ON-A-CHIP USING BIOPSY-DERIVED INTESTINAL ORGANOIDS FROM HEALTHY AND IBD PATIENTS

Duodenum Intestine-Chip for preclinical drug assessment in a human relevant model

Single cell transcriptomic analysis of the canine duodenum in chronic inflammatory enteropathy and health